How to manage no reflow phenomenon with local drug delivery via a rapid exchange catheter

Catheterization and Cardiovascular Interventions

Volumn 77, Issue 2, 2011, Pages 217-219

  Wilson, William ^a   Eccleston, David ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

angiography; ANGO; coronary; DDEL; drug delivery; no reflow; NRFL

Indexed keywords

GLYCERYL TRINITRATE; HEPARIN; VERAPAMIL;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CASE REPORT; FEMALE; HEART CATHETER; HUMAN; MALE; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CATHETERS; CORONARY ANGIOGRAPHY; DRUG ADMINISTRATION ROUTES; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITROGLYCERIN; NO-REFLOW PHENOMENON; TREATMENT OUTCOME; VASODILATOR AGENTS; VERAPAMIL;

EID: 79751488407     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22722     Document Type: Article

References (6)

1. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, Carrozza JP Jr, Kuntz RE, Baim DS,. Incidence and treatment of 'no-reflow' after percutaneous coronary intervention. Circulation 1994; 89: 2514-2518. (Pubitemid 24173664)
2. Lee CH, Wong HB, Tan HC, Zhang JJ, Teo SG, Ong HY, Low A, Sutandar A, Lim YT,. Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry. J Interv Cardiol 2005; 18: 261-266. (Pubitemid 41725551)
3. Hillegass WB, Dean NA, Liao L, Rhinehart RG, Myers PR,. Treatment of no-reflow and impaired flow with the nitric oxide donor nitroprusside following percutaneous coronary interventions: Initial human clinical experience. J Am CollCardiol 2001; 37: 1335-1343.
4. Wang HJ, Lo PH, Lin JJ, Lee H, Hung JS,. Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction. Catheter Cardiovasc Interv 2004; 63: 171-176. (Pubitemid 39313409)
5. Barcin C, Denktas AE, Lennon RJ, Hammes L, Higano ST, Holmes DR Jr, Garratt KN, Lerman A,. Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon. Catheter Cardiovasc Interv 2004; 61: 484-491. (Pubitemid 38419135)
6. Niccoli G, Burzotta F, Galiuto L, Crea F,. Myocardial no-reflow in humans. J Am Coll Cardiol 2009; 54: 281-292.